Point-of-care testing in the cardiovascular operating theatre
-
Urs E. Nydegger
Abstract
Point-of-care testing (POCT) remains under scrutiny by healthcare professionals because of its ill-tried, young history. POCT methods are being developed by a few major equipment companies based on rapid progress in informatics and nanotechnology. Issues as POCT quality control, comparability with standard laboratory procedures, standardisation, traceability and round robin testing are being left to hospitals. As a result, the clinical and operational benefits of POCT were first evident for patients on the operating table. For the management of cardiovascular surgery patients, POCT technology is an indispensable aid. Improvement of the technology has meant that clinical laboratory pathologists now recognise the need for POCT beyond their high-throughput areas.
Clin Chem Lab Med 2006;44:1060–5.
References
1. Lee-Lewandrowski E, Corboy D, Lewandrowski K, Sinclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003; 127:456–60.10.5858/2003-127-0456-IOAPSLSearch in Google Scholar
2. Lewandrowski K. How the clinical laboratory and the emergency department can work together to move patients through quickly. Clin Leadersh Manage Rev 2004; 18:155–9.Search in Google Scholar
3. Zhang WZ. Current situation of clinical chemistry in mainland China. Clin Chem Lab Med 2000; 38:1315–6.10.1515/cclm.2001.38.12.1315Search in Google Scholar
4. Hill AB, Nahrwold ML, Noonan D, Northrop P. A comparison of methods of blood withdrawal and sample preparation for potassium measurements. Anaesthesiology 1980; 53:606–63.10.1097/00000542-198007000-00012Search in Google Scholar
5. Burnett RW, Covington AK, Fogh-Andersen N, Kulpman WR, Maas AH, Muller-Plathe O. Recommendations on whole blood sampling, transport, and storage for simultaneous determination of pH, blood gases, and electrolytes. International Federation of Clinical Chemistry Scientific Division. J Int Fed Clin Chem 1994; 6:115–20.Search in Google Scholar
6. Borgdorff P, van den Berg RH, Vis MA, van den Bos GC, Tangelder GJ. Pump-induced platelet aggregation in albumin-coated extracorporeal systems. J Thorac Cardiovasc Surg 1999; 118:946–52.10.1016/S0022-5223(99)70066-8Search in Google Scholar
7. Sanders G, Opp M, McMurray J, Koeller U, Blaton V, Lund E, et al. The European Register for specialists in Clinical Chemistry and Laboratory Medicine: code of conduct. Clin Chem Lab Med 2004; 42:563–5.10.1515/CCLM.2004.096Search in Google Scholar
8. Stief TW, Fareed J. Point of care: diagnostics in hemostasis – the wrong direction? Clin Appl Thromb Hemost 2003; 9:191–5.10.1177/107602960300900302Search in Google Scholar
9. Choi TS, Greilich PE, Shi C, Wilson JS, Keller A, Kroll MH. Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery. Am J Clin Pathol 2002; 117:74–8.10.1309/VRXF-C68K-PMU9-QDKWSearch in Google Scholar
10. Ambrose TM, Parvin CA, Mendeloff E, Luchtman-Jones L. Evaluation of the TAS analyzer and the low-range heparin management test in patients undergoing extracorporeal membrane oxygenation. Clin Chem 2001; 47:858–66.10.1093/clinchem/47.5.858Search in Google Scholar
11. Avendano A, Ferguson JJ. Comparison of Hemochron and HemoTex activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 23:803–4.10.1016/0735-1097(94)90636-XSearch in Google Scholar
12. Piffare R. Management of bleeding in cardiovascular surgery. Philadelphia, PA: Hanley & Belfus, 2000.Search in Google Scholar
13. Berdat PA, Gygax E, Nydegger UE, Carrel T. Short- and long-term mechanical cardiac assistance. Int J Artif Organs 2001; 24:263–73.10.1177/039139880102400504Search in Google Scholar
14. Nydegger U. Transfusion dependency of cardiovascular surgery – update 2005. Swiss Med Wkly. Revision submitted.Search in Google Scholar
15. Svenmarker S, Appelblad M, Jansson E, Haggmark S. Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec ACT and Hemochron Jr apparatus. Perfusion 2004; 19:289–94.10.1191/0267659104pf755oaSearch in Google Scholar PubMed
16. Dobkowski WB, Murkin JM. A risk-benefit assessment of aprotinin in cardiac surgical procedures. Drug Saf 1998; 18:21–41.10.2165/00002018-199818010-00003Search in Google Scholar PubMed
17. Kmiecik SA, Liu JL, Vaadia TS, Nichols JD, Kohtz RJ, Mills NJ, et al. Quantitative evaluation of hypothermia, hyperthermia, and hemodilution on coagulation. J Extra Corpor Technol 2001; 33:100–5.Search in Google Scholar
18. Khoschnewis S, Hannes FM, Tschopp M, Wuillemin WA. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method. Thromb Res 2004; 113:327–32.10.1016/j.thromres.2004.03.021Search in Google Scholar PubMed
19. Dorfman DM, Goonan EM, Beutilier MK, Jarolim P, Tanasijevica M, Goldhaber SZ. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med 2005; 10:23–7.10.1191/1358863x05vm587oaSearch in Google Scholar PubMed
20. Faraday N, Guallar E, Sera VA, Bolton ED, Scharpf RB, Cartarius AM, et al. Utility of whole blood hemostatometry using the clot signature analyzer for assessment of hemostasis in cardiac surgery. Anesthesiology 2002; 96:1115–22.10.1097/00000542-200205000-00014Search in Google Scholar PubMed
21. Johi RR, Cross MH, Hansbro SD. Near-patient testing for coagulopathy after cardiac surgery. Br J Anaesth 2003; 90:499–501.10.1093/bja/aeg032Search in Google Scholar PubMed
22. Rossi AF, Khan D. Point of care testing: improving pediatric outcomes. Clin Biochem 2004; 37:456–61.10.1016/j.clinbiochem.2004.04.004Search in Google Scholar PubMed
23. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575–8.10.1093/bja/86.4.575Search in Google Scholar PubMed
24. Kessler U, Jenni HJ, Zosso A, Zachariou Z, Nydegger U. Impact of haemodilution solutions on thrombelastography (TEG). Haemostaseologie 2006; 26:A26–7.10.1038/sj.jp.7211613Search in Google Scholar PubMed
25. Engstrom M, Reinstrup P, Schott U. An in vitro evaluation of standard rotational thrombelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxyethyl starch. BMC Blood Disord 2005; 5:3.Search in Google Scholar
26. Sorensen ER, Lorme TB, Heath D. Thrombelastography: a means to transfusion reduction. Nurs Manage 2005; 36:27–33.10.1097/00006247-200505000-00010Search in Google Scholar PubMed
27. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43:1684–96.10.1093/clinchem/43.9.1684Search in Google Scholar
28. Farstad M, Andersen KS, Koller ME, Grong K, Sagadal L, Husby P. Rewarming from accidental hypothermia by extracorporeal circulation. A retrospective study. Eur J Cardiothorac Surg 2001; 20:59–64.Search in Google Scholar
29. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89:1–10.10.1111/j.1423-0410.2005.00648.xSearch in Google Scholar
30. Preusse CJ, Schulte HD. Extrakorporale Zirkulation heute. Darmstadt: Steinkopff Verlag, 1991.10.1007/978-3-642-85401-9Search in Google Scholar
31. Hardy JF. Current status of transfusion triggers for red blood cell concentrates. Transfus Apheresis Sci 2004; 31:55–66.10.1016/j.transci.2004.06.002Search in Google Scholar
32. Meier FA, Jones BA. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 2005; 129:1262–7.10.5858/2005-129-1262-PTESAASearch in Google Scholar
33. Kost GJ. Preventing medical errors in point-of-care testing: security, validation, safeguards, and connectivity. Arch Pathol Lab Med 2001; 125:1307–15.10.5858/2001-125-1307-PMEIPOSearch in Google Scholar
34. Queralto JM. The EC4 quality manual model. Clin Chim Acta 2001; 309:127–36.10.1016/S0009-8981(01)00510-1Search in Google Scholar
35. Di Serio F, Amodio G, Varraso L, Campaniello M, Coluccia P, Trerotoli P, et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Clin Chem Med Lab 2005; 43:202–9.10.1515/CCLM.2005.035Search in Google Scholar PubMed
36. Kitchen DP, Kitchen S, Jennings I, Woods TA, Walker ID, Preston FE. Point of care testing by health care professionals: current practice amongst the UK National External Quality Assessment Scheme Participants. Br J Haematol 2005; 130:318–21.10.1111/j.1365-2141.2005.05610.xSearch in Google Scholar PubMed
37. Collison B. An academic degree doesn't always mean better bedside care. RN 2005; 68:12–14.Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Point-of-care testing – can we move from anecdote to evidence?
- A long and winding road: defining the biological role and clinical importance of paraoxonases
- Point-of-care testing in the cardiovascular operating theatre
- Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause
- The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea
- Exploring allelic imbalance within paraffin-embedded tumor biopsies using pyrosequencing technology
- Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time
- Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe
- Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C>T) mutation
- Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients
- Protein Z levels and prognosis in patients with acute coronary syndromes
- Determination of total bilirubin in whole blood from neonates: results from a French multicenter study
- Analysis of protein S-100B in serum: a methodological study
- Lipid peroxidation and homocysteine levels in Behçet's disease
- Lower expression of the α2,3-sialylated fibronectin glycoform and appearance of the asialo-fibronectin glycoform are associated with high concentrations of fibronectin in human seminal plasma with abnormal semen parameters
- Automated processing of whole blood samples for the determination of immunosuppressants by liquid chromatography tandem-mass spectrometry
- Role of methionine residues of albumin in T-R conversion of hemoglobin
- Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
- Significance of Elecsys® S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients
- IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): Scientific Division, Committee on Reference Systems for Enzymes (C-RSE): Part 8. Reference procedure for the measurement of catalytic concentration of α-amylase: [α-Amylase: 1,4-α-D-glucan 4-glucanohydrolase (AMY), EC 3.2.1.1]
- ESEAP: the national External Quality Assessment Scheme for clinical chemistry in Greece and Cyprus
- Evaluation of whole-genome amplification using multiple-displacement amplification of a limited number of cells
- Comparison of various methods for the determination of total protein in urine
- Description of examinations and their results and ISO standard 15189
- Congress of Clinical Chemistry and Laboratory Medicine, Annual Congress of the Society of Clinical Chemistry and Laboratory Medicine (DGKL) in association with The Austrian Society for Laboratory Medicine and Clinical Chemistry, The Swiss Society for Clinical Chemistry (SGKC), The German Association of Technical Assistants in Medicine (dvta), Mannheim, Germany, October 1st - 4th, 2006
- First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), Salzburg, October 4 – 7, 2006
Articles in the same Issue
- Point-of-care testing – can we move from anecdote to evidence?
- A long and winding road: defining the biological role and clinical importance of paraoxonases
- Point-of-care testing in the cardiovascular operating theatre
- Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause
- The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea
- Exploring allelic imbalance within paraffin-embedded tumor biopsies using pyrosequencing technology
- Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time
- Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe
- Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C>T) mutation
- Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients
- Protein Z levels and prognosis in patients with acute coronary syndromes
- Determination of total bilirubin in whole blood from neonates: results from a French multicenter study
- Analysis of protein S-100B in serum: a methodological study
- Lipid peroxidation and homocysteine levels in Behçet's disease
- Lower expression of the α2,3-sialylated fibronectin glycoform and appearance of the asialo-fibronectin glycoform are associated with high concentrations of fibronectin in human seminal plasma with abnormal semen parameters
- Automated processing of whole blood samples for the determination of immunosuppressants by liquid chromatography tandem-mass spectrometry
- Role of methionine residues of albumin in T-R conversion of hemoglobin
- Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
- Significance of Elecsys® S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients
- IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): Scientific Division, Committee on Reference Systems for Enzymes (C-RSE): Part 8. Reference procedure for the measurement of catalytic concentration of α-amylase: [α-Amylase: 1,4-α-D-glucan 4-glucanohydrolase (AMY), EC 3.2.1.1]
- ESEAP: the national External Quality Assessment Scheme for clinical chemistry in Greece and Cyprus
- Evaluation of whole-genome amplification using multiple-displacement amplification of a limited number of cells
- Comparison of various methods for the determination of total protein in urine
- Description of examinations and their results and ISO standard 15189
- Congress of Clinical Chemistry and Laboratory Medicine, Annual Congress of the Society of Clinical Chemistry and Laboratory Medicine (DGKL) in association with The Austrian Society for Laboratory Medicine and Clinical Chemistry, The Swiss Society for Clinical Chemistry (SGKC), The German Association of Technical Assistants in Medicine (dvta), Mannheim, Germany, October 1st - 4th, 2006
- First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC), Salzburg, October 4 – 7, 2006
